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Introduction {#sec1}
============

The occurrence of *de novo* chromosomal abnormalities is a major problem in the use of assisted reproductive technology. Understanding when and how these genomic errors occur is essential to the field of reproductive medicine. In a preimplantation genetic testing for aneuploidies (PGT-A) using 24-chromosome single-nucleotide polymorphisms, approximately 40% of human embryos were found to be aneuploid ([@bib5]). Aneuploidy as a consequence of meiotic chromosome malsegregation is mainly the result of events in oocytes and not spermatocytes: the frequency of maternally derived aneuploidy increases from about 10%--20% to \>60% with increasing maternal age (reviewed in [@bib16]).

Another source of chromosomal anomalies in embryos is postfertilization mitotic division errors that result in embryonic mosaicism ([@bib34]). In contrast to meiotic errors, it was found that the incidence of mitotic aneuploidy was not associated with maternal age in either day 3 blastomere biopsies or day 5 trophectodermal biopsies ([@bib3], [@bib22]). A PGT-A of 28,052 day 3 human embryos indicated that more than 25% harbored aneuploidies of mitotic origin; moreover, the incidence of mitotic aneuploidy exceeded maternally derived meiotic aneuploidy in embryos of women less than 40 years old (reviewed in [@bib21]). These mitotic errors produce karyotypically distinct cell lineages within an embryo, which is then termed a mosaic embryo. Mosaicism occurs in ∼15%--90% of all cleavage stage human embryos ([@bib4], [@bib14], [@bib26]). [@bib18] showed that 48% (43/89) of cleavage-stage embryos contained two or more abnormal nuclei; moreover, DNA damage, as indicated by γ-H2AX (phosphorylated \[Ser139\] histone H2A.X) and replication protein A (RPA) staining, was significantly elevated in cells with micronuclei (74/85, 62/85) compared with cells with normal nuclear morphology (60/642, 36/642) ([@bib18]). Nevertheless, little is known about the molecular basis of mitotic errors and the consequences for mosaic embryonic survival.

After fertilization, the maternal genetic program governed by maternally derived RNAs and proteins is switched to the embryonic genetic program by *de novo* transcription; this switch is termed zygotic genome activation (ZGA) ([@bib13]). Nuclear transfer experiments in human somatic cells have demonstrated that ZGA failure can lead to embryonic developmental arrest ([@bib25], [@bib38]). Therefore, ZGA is one of the first and most critical events in animal development. At present two ZGA genes that are specifically expressed during the activation process in embryonic stem cells (ESCs) have been identified, namely, *Zscan4* and *Hmgpi. Zscan4* is essential for long-term culture of ESCs and maintenance of chromosomal integrity during telomere elongation ([@bib10], [@bib39]). *Hmgpi* is responsible for DNA replication and has a role in peri-implantation development and ESC isolation ([@bib37]).

Another ZGA gene, *Zscan5b*, is predicted to encode a SCAN domain with C2H2 zinc fingers (C2H2-ZF). Zinc-finger genes represent a significant portion of the genes in the vertebrate genome (reviewed in [@bib6]). The DNA-binding sites, interacting proteins, and transcriptional responses to genetic perturbation of C2H2-ZF proteins have recently been characterized ([@bib28]). The SCAN domain, a leucine-rich region, functions as a protein interaction domain that mediates self-association or selective association with other proteins ([@bib6]). These structural characteristics suggest that *Zscan5b* plays a role in genomic stability either independently or in combination with other factors for telomere elongation, such as *Zscan4* ([@bib39]), or for apoptosis-dependent DNA damage response, such as *Zscan10* ([@bib30]).

Although the origins of chromosomal abnormalities are well documented in the literature and are known to contribute to female infertility, the molecular mechanisms of these abnormalities are not well understood. In the present study, we hypothesized that the ZGA gene *Zscan5b* is involved in genome stability during mitosis. We tested this hypothesis by determining whether *Zscan5b*-deficient mice could act as a model for spontaneous mitotic chromosomal errors, and also investigated the roles of this ZGA gene in genome stability after fertilization and in developmental competency. Our analyses show that *Zscan5b* deficiency causes chromosomal abnormalities, and leads to the growth of early-stage cancerous lesions.

Results {#sec2}
=======

Gene Structure and Expression of the ZGA Gene *Zscan5b* {#sec2.1}
-------------------------------------------------------

An *in silico* analysis showed that mouse *Zscan5b* was expressed specifically in preimplantation embryos. Gene expression profiling indicated that *Zscan5b* transcript levels were upregulated during ZGA at the one- to four-cell embryo stages ([@bib2], [@bib13], [@bib35]) ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). RNA sequencing analysis of preimplantation embryos indicated that human *ZSCAN5B* levels peaked at the eight-cell stage ([Figure S1](#mmc1){ref-type="supplementary-material"}C) ([@bib2]), suggesting that human *ZSCAN5B* is also transcribed zygotically during the major burst of ZGA. Three primate-specific paralogs, *ZSCAN5A*, *ZSCAN5C*, and *ZSCAN5D*, have been identified that are divergent from the parental gene ([@bib32]); the level of primate ZSCAN5A peaked at the eight-cell stage ([Figure S1](#mmc1){ref-type="supplementary-material"}D) ([@bib2]). Analysis of a public expressed sequence tag (EST) database identified 21 cDNA clones that were found exclusively in preimplantation embryos (two-cell to morula stages) ([Figure S1](#mmc1){ref-type="supplementary-material"}E). One of these clones (AK13965.1) contained the full *Zscan5b* gene coding sequence, which spans 1,980 bp and has 2 exons; SMART domain prediction analysis indicated the gene encodes a putative protein of 468 amino acids ([NP_001028965.1](ncbi-p:NP_001028965.1){#intref0010}) that harbors a SCAN domain and five zinc-finger domains ([@bib29]) ([Figure S1](#mmc1){ref-type="supplementary-material"}F). In the NCBI Gene database, the *Zscan5b* gene has three transcripts (splice variants). Two of three splice variants contain a full-length open reading frame encoding a single protein model. The *Zscan5b* gene is predicted to be conserved in *Homo sapiens*, and pairwise alignment scores by a BLAST search of amino acid sequences for the human ortholog indicated 54% similarity ([Figure S1](#mmc1){ref-type="supplementary-material"}G).

Experimental analyses were carried out to confirm the results of the *in silico* analysis that indicated a preimplantation stage-specific expression pattern for *Zscan5b*. A real-time PCR analysis using cDNA isolated from mouse adult tissues and fetuses (embryonic day \[E\]7, E11, E15, and E17) detected *Zscan5b* expression in all tested tissues ([Figure 1](#fig1){ref-type="fig"}A). Real-time qPCR analysis of preimplantation embryos indicated that *Zscan5b* mRNA levels increased during the one- to two-cell stages, peaked at the four-cell stage, and then gradually decreased during the eight-cell to blastocyst stages ([Figures 1](#fig1){ref-type="fig"}B, [S1](#mmc1){ref-type="supplementary-material"}H, and S1I). The real-time qPCR results were separately normalized against the internal standard genes *Chuk*, *H2afz*, and *Gapdh* ([@bib9], [@bib20]) to ensure their reproducibility. The normalization procedure confirmed the *in silico* prediction of a preimplantation stage-specific expression pattern of *Zscan5b*. Expression of *Zscan5b* was found in isolated mouse ESCs, whereas it was downregulated in differentiated tissues (embryoid bodies) ([Figure 1](#fig1){ref-type="fig"}C). We then performed real-time qPCR analysis using α-amanitin, an RNA polymerase II inhibitor, to investigate *de novo* (zygotic) transcription of the *Zscan5b* gene. The presence of α-amanitin during *in vitro* culture from the one-cell stage significantly reduced *Zscan5b* mRNA expression in embryos at 43 and 53 h posthuman chorionic gonadotropin (hCG) (early and late two-cell stages, respectively) ([Figure 1](#fig1){ref-type="fig"}D), suggesting that *Zscan5b* is transcribed zygotically during the major burst of ZGA. Our results contradict a previous report showing ubiquitous expression of *Zscan5b* ([@bib32]), although both studies detected high expression in early embryos and in the testis.Figure 1*Zscan5b* Is a Zygotic Genome Activation Gene which Is Specifically Expressed during Preimplantation Stages and in Embryonic Stem Cells(A) Real-time qPCR analysis of *Zscan5b* expression in adult tissues and during postimplantation development (E7--E17). mRNA was isolated from mouse tissues (B, brain; H, heart; K, kidney; Li, liver; Lu, lung; M, muscle; S, spleen; T, testis). The expression levels were normalized against the reference gene *Gapdh*. Values are means ± SEM from three technical replicates.(B) Real-time qPCR analysis of *Zscan5b* expression during preimplantation development. Three sets of 10 pooled embryos were collected from unfertilized eggs (U), fertilized eggs (F), two-cell embryos (2), four-cell embryos (4), eight-cell embryos (8), morulae (M), and blastocysts (B) are shown after normalization to an internal reference gene (mouse *Chuk*). Values are means ± SEM from four separate experiments. The total number of samples and the number of individual experiments (in parentheses) contributing to a particular experiment are indicated above each column.(C) *Zscan5b* is transcribed in embryonic stem cells (ESCs), but not in differentiated embryoid bodies (EBs). The expression levels were normalized against the reference gene *Gapdh*. Values are means ± SEM from three separate experiments. The total number of samples and the number of individual experiments (in parentheses) contributing to a particular experiment are indicated above each column.(D) *De novo* (zygotic) transcription of the *Zscan5b* gene. Application of α-amanitin, an RNA polymerase II inhibitor, showed that *Zscan5b* is transcribed zygotically, but not maternally. *Zscan5b* expression was not observed before the two-cell stage, and α-amanitin completely inhibited *de novo* transcription at the two-cell stage. The expression levels were normalized using *H2afz* as a reference gene. Values are means ± SEM from two separate experiments. The total number of samples and the number of individual experiments (in parentheses) contributing to a particular experiment are indicated above each column.(E) Immunocytochemical analysis of ZSCAN5B expression. Preimplantation embryos were immunostained with an anti-ZSCAN5B antibody (green). Nuclei are shown by DAPI staining (blue). ZSCAN5B protein was detected throughout the preimplantation embryo stages. Scale bars represent 10 μm.(F) Nuclear translocation of ZSCAN5B protein during preimplantation development. ZSCAN5B was mainly detected in the nucleus of preimplantation embryos. Nuclei are shown by immunostaining with DAPI staining (blue). The total number of samples and the number of individual experiments (in parentheses) contributing to a particular experiment are indicated above each column.(G) ESC colony stained with antibodies against *Zscan5b* (red) and *Oct4* (green), and with DAPI. ZSCAN5B is distributed as dot-like foci in the nucleus, in contrast to the pattern by ZSCAN4 ([@bib10]).

Level of the ZSCAN5B Protein {#sec2.2}
----------------------------

To study the temporal and spatial distribution of the protein (ZSCAN5B) encoded by *Zscan5b* in mice, we raised a polyclonal antibody against ZSCAN5B peptides. Our gene expression analysis indicated that *Zscan5b* transcription started at the two-cell stage, peaked at the four-cell stage, and then gradually decreased until the blastocyst stage ([Figure 1](#fig1){ref-type="fig"}E); immunostaining with the polyclonal antibody showed the presence of ZSCAN5B from the two-cell stage until the blastocyst stage. ZSCAN5B was also present in both inner cell mass cells and trophectodermal cells of blastocysts.

ZSCAN5B was detected in the cell nucleus and cytoplasm throughout the preimplantation development ([Figures 1](#fig1){ref-type="fig"}E and 1F); however, it was exclusively localized to nuclei in eight-cell, morula, and late-blastocyst stages. ESCs isolated from blastocyst embryos were ZSCAN5B positive, with distribution mainly restricted to the nucleus, suggesting a specific role as a nuclear protein in preimplantation embryos and ESCs ([Figure 1](#fig1){ref-type="fig"}G). We also found that the OCT4 protein colocalized with ZSCAN5B in the nucleus of ESCs ([Figure 1](#fig1){ref-type="fig"}G). These results indicate that ZSCAN5B is a putative nuclear protein.

*Zscan5b* Is Not Essential for Fertility {#sec2.3}
----------------------------------------

Our *in silico* analysis demonstrated that the *Zscan5b* gene consisted of seven exons ([Figure S1](#mmc1){ref-type="supplementary-material"}F). To investigate the function of the ZSCAN5B protein in ESCs, we constructed a plasmid, pNT1.1, carrying a modified *Zscan5b* sequence in which the second and third exons were replaced with a neomycin resistance cassette (*Neo*) ([Figure 2](#fig2){ref-type="fig"}A). The construct was introduced into C57BL/6 mouse ESCs by electroporation, and colonies with resistance to the drug G-418 were screened for homologous recombination. Using the *Neo* targeting vector, 192 colonies were screened by Southern blotting (data not shown), and 14 (7.3%) heterozygous ESCs were isolated. To study the *in vivo* function of *Zscan5b*, we injected five *Neo* heterozygous ESC lines into C57BL/6 blastocysts. Germline transmission was obtained from three independent ESC clones. Among 64 mice born from heterozygous intercrosses, 12 were wild-type, 27 were heterozygous, and 24 were homozygous. Litter sizes of the intercrossed homozygotes were not significantly lower than those of wild-type mice ([Figures 2](#fig2){ref-type="fig"}B and 2C). And intercrossed homozygous mice produced second-generation homozygotes.Figure 2Differential Potential of *Zscan5b*-Deficient Mice and Embryos Derived from *Zscan5b*-Deficient ESCs(A) Chimeras generated by injection of *Zscan5b* heterozygous ESCs into ICR host blastocysts.(B) *Zscan5b*-deficient mice.(C) Average litter size of *Zscan5b*-deficient mice compared with wild-type mice (p *= 0.2145*).

*Zscan5b* Is Not Essential for Acquiring Self-Renewal Potential in the Derivation of ESCs {#sec2.4}
-----------------------------------------------------------------------------------------

To identify ESCs homozygous for the introduced gene mutation, blastocysts were tested in an outgrowth assay. *Zscan5b*-deficient embryos showed vigorous outgrowth, leading to the derivation of ESCs that were alkaline phosphatase (ALP) positive ([Figure 3](#fig3){ref-type="fig"}A). Thirteen *Zscan5b* homozygous ESC lines were isolated, and these clones were confirmed to be homozygous for the *Zscan5b* mutation by Southern blotting ([Figure 3](#fig3){ref-type="fig"}B) and genomic PCR ([Figure 3](#fig3){ref-type="fig"}C). Revserse transcription PCR and real-time qPCR analysis further confirmed the lack of *Zscan5b* expression in homozygous cells ([Figures 3](#fig3){ref-type="fig"}D and 3E). All of these cell lines were positive for pluripotency markers ([Figures 3](#fig3){ref-type="fig"}E--3I). To test whether *Zscan5b* contributes to normal development, a chimera assay was performed; this assay indicated that *Zscan5b*-deficient ESCs could contribute to the whole body ([Figures 3](#fig3){ref-type="fig"}J and 3K). These results suggest that *Zscan5b* does not contribute to ESC derivation or stemness as pluripotent stem cells.Figure 3Expression of Pluripotency Markers in *Zscan5b*-Deficient ESCs Is Comparable with Wild-Type ESCs(A) A *Zscan5b*-deficient blastocyst and blastocyst outgrowth are shown in the upper panel. Morphological appearance of *Zscan5*-deficient ESCs and ALP staining (purple) of *Zscan5b*-deficient ESCs are shown in the lower panel. Scale bars represent 200 and 50 μm.(B and C) Southern blotting analysis-based genotyping (B) and PCR-based genotyping (C) to distinguish between wild-type, *Zscan5b* heterozygous (+/−) and *Zscan5b*-deficient (−/−) ESCs.(D) Reverse transcription PCR analysis of *Zscan5b* mRNA expression in wild-type and *Zscan5b*^−/−^ ESCs.(E) Real-time qPCR analysis of *c*-*Myc*, *Nanog*, *Oct4*, *Sox2*, *Klf4*, and *Zscan5b* in wild-type and *Zscan5b*^−/−^ ESCs. The cell line number is shown above each bar, and the number shown in the parentheses indicates four independent experiments. Error bars, SEM. N.S., not significant.(F and G) Immunofluorescence staining for (F) ZSCAN5B (red) and OCT4 (green), (G) NANOG (red), SSEA1 (green), and SOX2 (red) in wild-type and *Zscan5b*^−/−^ ESC colonies as observed under confocal microscopy. Nuclei are stained with DAPI (blue). Scale bars represent 10 μm.(H and I) Immunoblot analysis of OCT4 and NANOG in wild-type and *Zscan5b*^−/−^ ESCs (H). The expression levels were normalized using actin expression (42 kDa) as a reference (I). The observed cell line number is shown above each bar, and the number shown in the parentheses indicates two independent experiments. Error bars, SEM. N.S., not significant.(J) Fluorescence microscopic images of EGFP-*Zscan5b*-deficient ESC colonies. These ESC colonies showed constitutive expression of EGFP. Scale bars represent 200 μm.(K) EGFP-*Zscan5b*-deficient chimera mouse. Fluorescence stereomicroscopic image of an embryo at E12.5 generated from blastocysts injected with EGFP-*Zscan5b*-deficient ESCs. The contribution of EGFP-*Zscan5b*-deficient ESCs was detected throughout the whole body.

Differentiation Assays *In Vitro* and *In Vivo* {#sec2.5}
-----------------------------------------------

In embryoid bodies, *Zscan5b*-deficient ESC lines gave rise to cell types in all three germ layers ([Figure 4](#fig4){ref-type="fig"}A). Surprisingly, on transplantation into immunocompromised mice, all *Zscan5b* homozygous ESC lines developed small malignant germ cell tumors ([Figure 4](#fig4){ref-type="fig"}B). The tumors primarily exhibited the histology of mature teratomas, and consisted of tridermic elements, with scattered foci of immature teratomas mainly consisting of neural tissues. Furthermore, adjacent to the immature teratoma components, a small number (1--3 per tumor) of tiny foci with malignant germ cell tumor components, histologically distinct from the immature teratoma cells, were present. The size of these lesions ranged from 0.5 to 3 mm in diameter, with most being around 1 mm. We classified these lesions as choriocarcinomas and embryonal carcinomas. However, the very small sizes and the multiplicity of these apparently malignant germ cell tumor components, in addition to the absence of metastatic lesions outside the tumor, might indicate that they were very early-stage cancerous lesions rather than authentic, fully malignant germ cell tumors with metastasizing potential. The tumor sizes developed from *Zscan5b*-deficient ESC lines was comparable with that from wild-type ESC lines ([Figures 4](#fig4){ref-type="fig"}C and 4D).Figure 4Injection of *Zscan5b*-Deficient ESCs Results in the Growth of Very Early-Stage Cancerous Lesions(A) Embryoid bodies (EBs) differentiated from *Zscan5b*-deficient ESCs are stained with AFP (green), TUJ1 (green), and SMA (green), respectively. Nuclei are stained with DAPI (blue). Scale bars represent 50 μm.(B) Teratoma formation assay. (i--iii) Choriocarcinoma. (i) Low-power micrograph shows a hemorrhagic lesion with large, atypical trophoblastic cells. (ii) Higher magnification reveals two types of cell, namely, cytotrophoblast-like cells (white arrowhead) and syncytiotrophoblasts (yellow arrowhead). (iii) Immunohistochemistry for hCG demonstrates positive staining in the latter type of cells, whereas the former type is negative (arrowhead). (iv--vi) Embryonal carcinoma. (iv) Low-power micrograph shows an alveolar structure consisting of solid sheets of monotonous atypical cells. (v) Higher magnification reveals cohesive cells with indistinct cytoplasmic border and large nuclei with prominent nucleoli, characteristic features of embryonal carcinomas. Many mitotic figures are seen (asterisk). (vi) Immunohistochemistry for OCT4 demonstrates positive staining in the nuclei of the tumor cells. Scale bars, 200 μm (i), 100 μm (ii--iv, vi), and 20 μm (v).(C and D) Tumor sizes (C) and weights (D) derived from *Zscan5b*-deficient ESCs are comparable with teratomas from wild-type ESCs. Error bars, SEM. N.S., not significant.

DNA Repair Is Mediated through *Zscan5b* {#sec2.6}
----------------------------------------

The mechanisms underlying the tumorigenic characteristics of *Zscan5b*-deficient ESCs were investigated by X-irradiating the cells and staining for the DNA damage markers γH2AX and RPA. γH2AX foci in nuclei were significantly more frequent in *Zscan5b*-deficient ESCs than in wild-type ESCs ([Figures 5](#fig5){ref-type="fig"}A and 5B). Also, the number of foci of RPA, a single-strand DNA-binding protein, in *Zscan5b*-deficient ESCs was increased (not significantly) ([Figures 5](#fig5){ref-type="fig"}C and 5D), indicating the presence of DNA damage such as DNA double-strand breaks during mitosis.Figure 5Genomic Instability in *Zscan5b*-Deficient Cells(A and B) Immunostaining for γ-H2AX indicating DNA damage (A) and mean γ-H2AX-positive foci (B) in irradiated *Zscan5b*-deficient ESCs. Scale bars represent 10 μm. The number of analyzed cells is shown above each bar, and the number shown in the parentheses indicates two independent experiments. Error bars, SEM.(C and D) Immunostaining for RPA (C) and mean RPA-positive foci (D) in *Zscan5b*-deficient irradiated ESCs. Scale bars represent 10 μm. The number of analyzed cells is shown above each bar, and the number shown in the parentheses indicates two independent experiments. Error bars, SEM. N.S., not significant.(E) Principal-component analysis of global gene expression patterns of *Zscan5b*^−/−^ ESC lines (shown in red) and wild-type ESC lines (blue).(F) Heatmap of most highly up- or downregulated genes in *Zscan5b*^−/−^ ESC lines in comparison with the control wild-type ESC lines and cluster diagram of global gene expression profile of *Zscan5b*-deficient ESC lines in comparison with the control wild-type ESC lines. Shown are the microarray expression ratios of each sample relative to the mean in the ESC samples (in a logarithmic scale). The red and green color ranges denote at least a 2-fold change.(G--I) Immunofluorescence staining for γ-H2AX (red) and GFP (green) (G), and ZSCAN5B (H) of wild-type irradiated ESCs, *Zscan5b*-deficient irradiated ESCs, *Zscan5b* rescued *Zscan5b*-deficient irradiated ESCs, and mean γ-H2AX-positive foci (I). Nuclei are stained for DAPI (blue). Scale bars represent 10 μm. The number of analyzed cells is shown above each bar, and the number shown in the parentheses indicates two independent experiments. Error bars, SEM. N.S., not significant.

Global transcriptional changes, including those of DNA repair genes, were investigated in a microarray analysis of three wild-type ESC lines and three *Zscan5b*-deficient ESC lines ([Tables S2](#mmc2){ref-type="supplementary-material"} and [S3](#mmc3){ref-type="supplementary-material"}). Using a clustering analysis, we found that the *Zscan5b*-deficient ESC lines grouped separately from the wild-type ESC cell lines ([Figures 5](#fig5){ref-type="fig"}E and 5F). In addition, all three *Zscan5b*-deficient ESC lines showed elevated expression of the DNA damage repair genes *Rad51l3* and *Bard1* ([Table S2](#mmc2){ref-type="supplementary-material"}), indicating that *Zscan5b* deficiency induces susceptibility to DNA damage.

To determine whether DNA damage repair depends on *Zscan5b*, a piggyBac vector carrying wild-type *Zscan5b*-GFP driven by a CAG promoter for long-term stable expression was transfected into *Zscan5b*-deficient ESCs. We found a significant increase in DNA damage after irradiation in *Zscan5b*-deficient ESCs. However, a lower frequency of γH2AX foci was present in transfected *Zscan5b*-deficient ESCs ([Figures 5](#fig5){ref-type="fig"}G--5I), suggesting that restoration of *Zscan5b* expression in these cells was sufficient to restore genome stability. Therefore, we conclude that DNA damage can be resolved through *Zscan5b*-dependent repair pathways.

*Zscan5b* Deficiency Increases Chromosomal Aberrations {#sec2.7}
------------------------------------------------------

Chromosome instability is a feature of many cancers and may be a crucial factor in carcinogenesis. We carried out a chromosomal analysis of *Zscan5b*-deficient ESCs and somatic cells of homozygous-deficient adult mice. Analysis of Q-banded chromosomes showed that they displayed an increasing number of chromosome breaks, defined as a disruption in the chromosome, in *Zscan5b*-deficient ESCs ([Figures 6](#fig6){ref-type="fig"}A, 6B, and [S3](#mmc1){ref-type="supplementary-material"}). Fusion of chromosome fragments and unrepaired chromosome breaks are known to be associated with cell malignancy (reviewed in [@bib33]). Somatic cells from *Zscan5b*-deficient adults showed chromosome instability with a significantly increased frequency of chromosome gaps, derivative chromosomes, gain or loss of chromosomes, Robertsonian translocations, and chromosome breaks ([Figure S4](#mmc1){ref-type="supplementary-material"}). In particular, the frequency of chromosome gaps in spleen cells of the *Zscan5b*-deficient mice was significantly higher than in those of wild-type mice (43.0% versus 1.3%, p \< 0.001). The positions of chromosome gaps were random in all chromosomes except chromosome 11 ([Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}; [Table S4](#mmc1){ref-type="supplementary-material"}). These results imply that *Zscan5b* deficiency can lead to chromosome instability and stochastically derived chromosome gaps may induce other chromosomal abnormalities such as chromosome breaks.Figure 6ZSCAN5B Binds to Histone H1(A and B) Chromosome breaks in *Zscan5b*-deficient ESCs (A). The error bars indicate SEM of two replicates of each cell line (B). The image shown in (A) is also shown in [Figure S3](#mmc1){ref-type="supplementary-material"}D.(C) IRES-EGFP vector of the *Zscan5b*^−/−^.(D) The vector transfected into ESCs (upper panel) expresses GFP (lower panel). Scale bars represent 50 μm.(E) Analytical gel electrophoresis of anti-Flag antibody-conjugated proteins extracted from ESCs. The gel was stained with the SilverQuest Silver Staining Kit (Invitrogen).(F) Liquid chromatography-mass spectrometry analysis of targeted bands 1, 2, and 4. ZSCAN5B binds to proteins of the histone H1 family.

ZSCAN5B Binds to Histone H1 {#sec2.8}
---------------------------

From the results of our various analyses, we propose that *Zscan5b* likely protects cells against a range of *de novo* chromosomal abnormalities during mitosis. We further speculate that ZSCAN5B binds either directly or indirectly to chromosomes, and helps to form nucleosome structures. To test these speculations, we performed a co-immunoprecipitation analysis using protein extracted from ESCs transfected with 3XFLAG-Zscan5b-EGFP ([Figures 6](#fig6){ref-type="fig"}C--6E). The components of bands from 3XFLAG-Zscan5b-EGFP combined proteins were analyzed and the histone H1 family, H1.1, H1.2, and H1.4, was specifically detected in bands 1, 2, and 4 of the antibody-added protein samples ([Figure 6](#fig6){ref-type="fig"}F). We cross-validated these results by an immunoprecipitation assay using cells transfected with a pcDNA3.1+C-eGFP plasmid carrying mouse *Zscan5b* cDNA and three pcDNA3.1-MYC-HIS A plasmids carrying mouse histone 1,1, 1.2, and 1.4 cDNAs ([Figure S5](#mmc1){ref-type="supplementary-material"}). The sizes of the bands corresponded to the molecular sizes of histones H1.1, H1.2, and H1.4 in the antibody-added protein sample. These results support our suggestion that ZSCAN5B binds to histones H1.1, H1.2, and H1.4.

Discussion {#sec3}
==========

Here we have demonstrated that a ZGA gene, *Zscan5b*, contributes to the maintenance of DNA integrity against cellular DNA damage and *de novo* chromosomal aberrations during mitosis, thereby preventing development of cancers. *Zscan5b*-deficient ESCs did not differ from wild-type ESCs in terms of pluripotency but did display a distinct range of abnormalities including elevated DNA stress and chromosomal abnormalities. Interestingly, spleen cells isolated from *Zscan5b*-deficient adult mice showed random distribution of gaps in their chromosomes; gaps were defined here as an unstained section in a chromatid. A co-immunoprecipitation analysis showed that ZSCAN5B bound to the linker protein histone H1, suggesting a role in chromatin dynamics during mitosis. Therefore, the *Zscan5b* gene can be classified as encoding a protein directly involved in DNA repair and protection of chromosomal architecture, and which contributes to preventing the formation of cancerous lesions.

ZSCAN Family Might Contribute to the Maintenance of Genomic Integrity {#sec3.1}
---------------------------------------------------------------------

Nuclear reprogramming during the preimplantation developmental period is crucial for genomic integrity. Although induced pluripotent stem cells (iPSCs) have similar pluripotency to ESCs, those derived from aged donors (A-iPSCs) show diminished DNA damage responses and a defect in the apoptotic response to DNA damage; as a consequence, A-iPSCs show a greater number of cells with genetic abnormalities ([@bib30]). Somatic cell nuclear transfer (SCNT) has shown that oocytes can reprogram somatic cells into pluripotent stem cells. Unlike A-iPSCs, stem cells derived by SCNT (ntESCs) using the genome of an aged donor and cytoplasm of a young donor (A-ntESCs) show normal DNA damage responses and normal genomic integrity ([@bib30]). The key difference here is that there are more reprogramming factors stored in oocytes; moreover, ZGA genes, including *Zscan5b*, are transcribed more efficiently during preimplantation embryo development than the four "Yamanaka" factors (OCT4, SOX2, KLF4, and c-MYC) ([@bib7]).

Another ZSCAN family gene, *ZSCAN10*, is specifically expressed in ESCs and iPSCs, and higher expression is shown in iPSCs from younger donors (Y-iPSCs) than in A-iPSCs. Overexpression of *ZSCNA10* in conjunction with the four Yamanaka factors can restore impaired genomic integrity in A-iPSCs ([@bib30]), implying that *ZSCAN10* is responsible for the poor DNA damage response and genomic instability in A-iPSCs. Although it is unclear whether ZSCAN family genes interact with each other, overexpression of the zygotic gene *Zscan5b* could play a role in restoring genome integrity through DNA repair after the initial DNA damage response in A-iPSCs similar to that in A-ntESCs, as shown here in the rescue experiments.

Origins of Chromosome Abnormalities in *Zscan5b*-Deficient Somatic Cells {#sec3.2}
------------------------------------------------------------------------

A clue to the origin of chromosome abnormalities in *Zscan5b*-deficient somatic cells can be obtained from the consequences of nuclear translocation of the ZSCAN5B protein. Our immunocytological analysis showed that the ZSCAN5B protein was present in both nuclei and cytoplasm at early preimplantation stages, but became predominantly localized to the nucleus from the eight-cell stage. Although the peptide antibody raised against synthetic peptides of ZSCAN5B did not demonstrate high specificity ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B), a bipartite nuclear localization signal peptide (RFQCTECKKSFLYKSRFDLHQRSHTGERPFKCILC) was present in the ZSCAN5B sequence based on the *in silico* analysis ([@bib19]). Thus, the nuclear localization of ZSCAN5B after the eight-cell stage implies a spatial requirement. The precise timing of formation of chromosomal abnormalities is unclear. Chromosome breaks were observed in one of the three *Zscan5b*-deficient ESC lines isolated from the inner cell mass of *Zscan5b*-deficient blastocysts. In addition, spleen cells from *Zscan5b*-deficient mice showed a range of chromosomal abnormalities. These observations imply that formation of chromosomal abnormalities is initiated from the peri-implantation period. Because chromosome fragments can induce other chromosome aberrations (reviewed in [@bib33]), these abnormalities might be accumulated during mitosis without *Zscan5b* expression.

*Zscan5b* Works as a DNA Damage Repair Gene {#sec3.3}
-------------------------------------------

*Zscan5b*-deficient ESCs differentiated into germ cell tumors with multilineage, differentiated cell types. Karyotype analysis of ESCs and spleen cells of *Zscan5b*-deficient adults identified chromosomal abnormalities, ranging from small insertions or deletions to large chromosomal alterations. The frequency of γ-H2AX foci in *Zscan5b*-deficient irradiated ESCs was significantly elevated compared with wild-type ESCs. *Zscan5b*-deficient irradiated ESCs also displayed a trend to increased frequency of RPA foci. RPA relocates into distinct nuclear foci and colocalizes with γ-H2AX at the sites of DNA damage in a time-dependent manner ([@bib1]). These results suggest that DNA repair processes after the initial DNA damage response do not work in *Zscan5b*-deficient ESCs. However, our rescue experiment showed the presence of a lower frequency of γH2AX foci ([Figures 5](#fig5){ref-type="fig"}H and 5I), suggesting that restoration of *Zscan5b* expression in *Zscan5b*-deficient ESCs was sufficient to restore genome stability. A global transcriptional analysis showed elevated expression of *Rad51l3* and *Bard1* in *Zscan5b*-deficient ESCs ([Table S2](#mmc2){ref-type="supplementary-material"}). RAD51 is a key component of the homologous recombination mechanism of DNA damage repair and is associated with the activation of double-strand break DNA repair ([@bib11]). BRCA1--BARD1 interacts with RAD51 directly, and BRCA1 performs several functions at the stalled fork and in double-strand break repair ([@bib40]). In addition, chromatin immunoprecipitation sequencing (ChIP-seq) showed that ZSCAN5B binds with the promoter region of *RAD51* ([@bib32]). These results suggest that *Zscan5b* regulates *Rad51* expression and is involved in postdamage DNA repair during mitosis.

*Zscan5b* Binds to Linker Histone H1 and Protects Chromatin Structure {#sec3.4}
---------------------------------------------------------------------

Immunoprecipitation assays using proteins extracted from ESCs and HeLa cells transfected with *Zscan5b* and vectors expressing histone proteins H1.1, H1.2, and H1.4 showed that the ZSCAN5B protein binds to histones H1.1, H1.2, and H1.4. [@bib15] reported that the linker protein histone H1 plays an important role in nucleosome spacing and interphase nuclear compaction. In addition, histone H1-null somatic mouse cells show an ∼7-fold increase in the rate of chromosomal aberrations, including chromosomal gaps and breaks, compared with wild-type cells ([@bib15]). These results suggest that ZSCAN5B is associated with histone H1 and contributes to the maintenance of chromosomal architecture.

*Zscan5b*-Deficient Mouse Is a Model of the Human Disease, Chromosome Instability Syndrome {#sec3.5}
------------------------------------------------------------------------------------------

The *Zscan5b*-deficient mouse cannot repair postreplication DNA damage, and shows an increase in chromosome aberrations including gaps, breaks, gain or loss of chromosomes, and Robertsonian translocations. Defective DNA repair is a common feature of chromosome instability syndromes, also known as chromosome breakage syndromes ([@bib32]). The classic chromosome instability syndromes are Fanconi pancytopenia syndrome, Bloom syndrome, and ataxia-telangiectasia. The diagnostic cytogenetic finding in Bloom syndrome is a marked increase in the level of spontaneous sister chromatid exchanges (SCEs). The normal rate of SCEs in human cells is 6--10; however, in Bloom syndrome, more than 50 SCEs per cell are found ([@bib8]). A Q-banding analysis of *Zscan5b*-deficient spleen cells showed the presence of chromosomal gaps; this phenotype resembles that of some chromosomal instability syndromes. We therefore analyzed SCE frequencies in *Zscan5b*-deficient spleen cells and wild-type somatic cells, but no significant differences in total SCE numbers were found: 8.20 in 18 wild-type cells; 8.35 in 20 *Zscan5b*-deficient somatic cells ([Figure S6](#mmc1){ref-type="supplementary-material"}). The gene for Bloom syndrome, *BLM*, encodes a protein that interacts with RAD51 protein to protect somatic cells against chromosomal aberrations ([@bib27]). Chromosome analysis showed that most mitotic metaphase cells with *Rad51* deficiency carried isochromatid-type breaks before cell death ([@bib31]). ZSCAN5B has been reported to bind to the promoter regions of the tumor suppressor genes *RAD51* and *BRCA1* in ChIP-seq analyses ([@bib32]). *BRCA1*, *BRCA2*, and *RAD51* can suppress an aberrant replicative homologous recombination response at stalled forks ([@bib36]). Our microarray data showed elevated expression of *Rad51l3* and *Bard1* in *Zscan5b*-deficient ESCs, implying that *Zscan5b* performs several functions as a transcription factor and in DNA double-strand break repair through interaction with these tumor suppressor genes. In addition, COSMIC (the Catalogue of Somatic Mutations in Cancer) (<http://www.sanger.ac.uk/cosmic>) indicates that mutation of the orthologous human gene *ZSCAN5B* occurs in ovarian cancer (COSP26515, COSU331), lung cancer (COSU418), and Fanconi anemia (COSP39462). Therefore, we propose that the *Zscan5b*-deficient mouse could be used as a model of chromosome breakage syndromes, and would be useful for exploring their origin and for developing treatment therapies.

Conclusion {#sec3.6}
----------

To our knowledge, this is the first report showing that the ZGA gene *Zscan5b* is involved in the maintenance of genomic integrity during mitosis. We propose that abnormal mitosis without the presence of *Zscan5b* induces genome instability and causes altered stem cell differentiation leading to tumorigenesis. In addition, *Zscan5b* might be involved in maintaining DNA structure in combination with histone H1 and for packaging chromosomes into a high order of chromatin structure to prevent chromosomal abnormalities. Testing this hypothesis will be carried out in subsequent investigations.

Experimental Procedures {#sec4}
=======================

Identification of the Mouse Zscan5b Gene by *In Silico* Analysis {#sec4.1}
----------------------------------------------------------------

Preimplantation-specific genes were identified by global gene expression profiling of oocytes and preimplantation embryos ([@bib13]) and EST frequencies in the Unigene database. SMART ([@bib29]) was used for domain prediction analysis.

Collection and Manipulation of Oocytes {#sec4.2}
--------------------------------------

Female B6D2F~1~ mice were superovulated at 6--8 weeks old by injection of 5 IU of pregnant mare serum gonadotropin (Sigma-Aldrich, St Louis, MO, USA), followed 48 h later by 5 IU of hCG (Sigma-Aldrich). Unfertilized eggs were harvested 18 h after the hCG injection by the standard method ([@bib23]), and cumulus cells were removed by incubation in M2 medium (EmbryoMax M2 Powdered Mouse Embryo Culture Medium; Millipore, Billerica, MA, USA) supplemented with 300 mg/mL hyaluronidase (Sigma-Aldrich). The eggs were then thoroughly washed, selected for good morphology, and collected. Fertilized eggs were also harvested from mated superovulated mice in the same way as unfertilized eggs; embryos with two pronuclei were collected to synchronize *in vitro* embryo development. Fertilized eggs were cultured in synthetic oviductal medium enriched with potassium (EmbryoMax KSOM Powdered Mouse Embryo Culture Medium; Millipore) at 37°C in an atmosphere of 95% air/5% CO~2~. Cultured blastocysts were transferred into the uteri of 2.5 d.p.c. (day post coitum) pseudopregnant ICR female mice as described previously ([@bib23]).

Ethical Approval for the Use of Animals {#sec4.3}
---------------------------------------

The Institutional Review Board of the National Research Institute for Child Health and Development (NRICHD, approval number A2006-009), Japan and of Keio University (approval number 10240-(1)) granted ethical approval for oocyte and embryo collection from the mice.

Blastocyst Outgrowth and ESC Isolation {#sec4.4}
--------------------------------------

The zona pellucida of blastocysts at 3.5 d.p.c. was removed using acidic Tyrode\'s solution (Sigma). The blastocysts were cultured individually in ES medium: KnockOut DMEM (Invitrogen) containing 15% KnockOut Serum Replacement (Invitrogen), 2,000 U/mL ESGRO (mouse leukemia inhibitory factor \[mLIF\]; Chemicon, Temecula, CA, USA), 0.1 mM nonessential amino acids, 2 mM GlutaMax (Invitrogen), 0.1 mM β-mercaptoethanol (Invitrogen), and penicillin/streptomycin (50 U/50 mg/mL; Invitrogen) on irradiated mouse embryonic fibroblast (MEF) cells at 37°C in an atmosphere of 5% CO~2~ according to a standard procedure ([@bib23]). The cultured cells were examined and photographed daily. After 1 week, proliferating cells were trypsinized using Accutase (Invitrogen), and passaged onto new MEF plates. After two more passages, mouse ESC lines were isolated.

Blastocyst Injections to Produce Chimeras {#sec4.5}
-----------------------------------------

To visualize the *in vivo* contribution of *Zscan5b*-deficient ESCs, *Zscan5b*-deficient ESCs were electroporated with the piggyBac transposon gene expression vector and transposase-expressing vector using a 4D-nucleofector device ([@bib17]). We isolated the GFP-positive *Zscan5b*-deficient ESCs (EGFP-*Zscan5b*-deficient ESCs) line, which was continuously cultured on feeder layers in mouse ESC medium with LIF. EGFP-*Zscan5b*-deficient ESCs were injected into blastocysts of B6D2F1 mice, then transferred to the uteri of pseudopregnant ICR mice. Embryos were dissected on E14.5 and the contribution of ESCs to embryos was assessed using a fluorescence stereomicroscope (MVX10, OLYMPUS, Japan).

Irradiation {#sec4.6}
-----------

Irradiation of mouse ESCs was performed as previously described ([@bib12]). In brief, cells were given 4 Gy of X-rays, using a CELLRAD (Faxitron Bioptics, Tuscon, AZ, USA). Immediately after irradiation, cells were returned to the incubator at 37°C in a humidified atmosphere containing 95% air and 5% CO~2~, and incubated until further processing. Cell numbers were counted using a TC20 automated cell counter (Bio-Rad Laboratories, Hercules, CA, USA).

Transfection with Zscan5b Constitutive Expression Plasmid {#sec4.7}
---------------------------------------------------------

*Zscan5b*-deficient ESCs were washed with PBS once, detached by Accutase and suspended in ESC derivation medium. Cells were dissociated into a single-cell suspension by vigorous pipetting and counted. Pellets were made and mixed with 1 μg of transposase-expressing vector and 1 μg of the piggyBac transposon gene expression vector (pPB-CAG-mZscan5b-P2A-EGFP) ([@bib24]) purchased from VectorBuilder in 100 μL of P2 primary cell nucleofector solution (Lonza, Switzerland). The cell suspension was transferred to a cuvette and electroporated using a 4D-nucleofector device (Lonza) with program CG-104 following the manufacturer\'s protocol. The electroporated cells were plated onto a six-well plate on MEF in mouse ESC medium. The GFP-positive colonies were picked up and the clonal lines were maintained as rescued *Zscan5b*-deficient mouse ESCs (res-Zscan5b-deficient ESCs).

Statistical Analysis {#sec4.8}
--------------------

A chi-square test or a one-way ANOVA with Bonferroni\'s multiple comparison testing was used for statistical analyses. Statistical analyses were performed using GraphPad Prism software (GraphPad, San Diego, CA, USA). p \< 0.05 was considered to indicate statistical significance (^∗^p \< 0.05, ^∗∗∗∗^p \< 0.0001).
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